Insider trading on March 6, 2026
119 insiders at 96 companies bought $55M of their own stock on the open market, across 143 transactions. The largest was ARCH Venture Partners IX, LLC, 10% Owner, buying $12.5M of Lyell Immunopharma, Inc. (LYEL).
22 chief executives bought: Jenisch Jan Philipp at AMRZ, Sudhir Srivastava at SSII, Gokey Timothy C at BR and 19 more.
Insiders sold $678.9M across 359 open-market sales. That is 12.3× the value bought. Selling routinely outweighs buying, because most executive pay is delivered in stock.
Open-market purchases
Code P only — insiders spending their own money, largest first.
Open-market sales
Pre-arranged 10b5-1 trades are marked.